ImmunityBio, Inc.
IBRX
$7.77
-$0.29-3.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 132.58% | 518.40% | 62.09% | 97.76% | -29.51% |
| Total Receivables | 139.58% | 147.95% | 1,506.37% | 587.54% | 983.98% |
| Inventory | -70.78% | -93.52% | -89.00% | 242.34% | 266.65% |
| Prepaid Expenses | 65.11% | 38.90% | 0.71% | 25.02% | 39.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 15.87% | 64.05% | 14.35% | 0.04% |
| Total Current Assets | 110.91% | 314.93% | 70.58% | 101.96% | -14.29% |
|
|
|||||
| Total Current Assets | 110.91% | 314.93% | 70.58% | 101.96% | -14.29% |
| Net Property, Plant & Equipment | -13.29% | -12.56% | -13.44% | -6.40% | -4.42% |
| Long-term Investments | -- | 0.00% | 0.00% | 0.00% | -- |
| Goodwill | -- | 0.00% | 0.00% | 0.00% | -- |
| Total Other Intangibles | -15.86% | -17.60% | -13.18% | -12.87% | -12.40% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 212.51% | 204.52% | 0.53% | 4.92% | 6.15% |
| Total Assets | 56.31% | 112.88% | 31.07% | 42.36% | -9.51% |
|
|
|||||
| Total Accounts Payable | 61.73% | -17.10% | 3.76% | -41.95% | -63.48% |
| Total Accrued Expenses | 65.29% | 75.36% | 9.75% | -0.95% | 0.04% |
| Short-term Debt | -- | -- | 40.30% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.64% | 2.94% | 1.62% | 4.73% | 18.66% |
| Total Finance Division Other Current Liabilities | -39.37% | 25.26% | 179.97% | 120.70% | 15.20% |
| Total Other Current Liabilities | -39.37% | 25.26% | 179.97% | 120.70% | 15.20% |
| Total Current Liabilities | 51.50% | 38.10% | 12.39% | -6.28% | -18.46% |
|
|
|||||
| Total Current Liabilities | 51.50% | 38.10% | 12.39% | -6.28% | -18.46% |
| Long-Term Debt | 48.84% | 38.45% | 7.43% | -16.02% | -16.43% |
| Short-term Debt | -- | -- | 40.30% | -- | -- |
| Capital Leases | -13.00% | 0.79% | -3.30% | -6.50% | -0.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 337.90% | 1,008.29% | 197.98% | 250.31% | -1.01% |
| Total Liabilities | 72.27% | 69.50% | 14.97% | -5.98% | -14.87% |
|
|
|||||
| Common Stock & APIC | 16.65% | 19.65% | 10.82% | 21.96% | 19.04% |
| Retained Earnings | -27.59% | -24.38% | -10.41% | -10.51% | -11.36% |
| Treasury Stock & Other | 117.09% | 37.57% | 2,317.03% | 4,751.46% | 157,200.00% |
| Total Common Equity | -83.38% | -47.10% | -2.32% | 29.64% | 18.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -83.38% | -47.10% | -2.32% | 29.64% | 18.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -6.67% | -7.27% | -7.64% | -7.81% | -7.83% |
| Total Equity | -83.53% | -47.19% | -2.34% | 29.66% | 18.29% |
|
|
|||||